Purpose: Pharmacokinetic and safety data related to the use of inhaled insulin for the management of diabetes mellitus are discussed. The various pulmonary insulin delivery systems under ...

Pulmonary administration of insulin (inhaled insulin) results in rapidly discernible plasma insulin levels and glucose-lowering effect, albeit with a bioavailability that is 10-26% that of ...

MannKind Co. (NASDAQ:MNKD – Get Free Report) has received a consensus rating of “Buy” from the eight brokerages that are ...

The U.S. Food and Drug Administration has approved inhalable insulin to help patients control their blood sugar levels. ManKind Corporation's Afrezza is a fast-acting form of insulin intended for ...

Clinical programs for inhaled insulin have received several setbacks of late, with Bagsværd, Denmark-based Novo Nordisk deciding in January to terminate phase 3 trials of its inhaler and ...

After 11 years of development and barely one full year of sales, New York–based Pfizer dumped the much-anticipated inhaled powder insulin product Exubera on 18 October. This was particularly bad ...

Prices for insulin, the essential drug for treating diabetes, have plummetted to their lowest levels in a decade following a rise in generic options. In ...

This rapid-acting inhaled insulin mimics the body’s natural insulin response, working within 12-15 minutes and clearing in 2-3 hours for better blood sugar control. Its small, needle-free ...

Developing a convenient delivery method for insulin that does not require injection is the holy grail of diabetes management. The announcement that inhaled insulin will soon be available in India has ...

Our Bureau, Mumbai Thursday, January 30, 2025, 17:40 Hrs [IST] ...